A. Joseph , C. Agbakwuru , A. Akinsete , A. Oladipo , N. Adedewe , K. Badejoko , M. Mangongolo , A. Kotkat , O. Fagbemide , B. Saba
{"title":"Advancing Pediatric Radiation Therapy in sub-Saharan Africa: Report from a Pediatric Radiation Oncology Program in Nigeria","authors":"A. Joseph , C. Agbakwuru , A. Akinsete , A. Oladipo , N. Adedewe , K. Badejoko , M. Mangongolo , A. Kotkat , O. Fagbemide , B. Saba","doi":"10.1016/j.ijrobp.2024.11.040","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Pediatric radiation oncology is a rapidly emerging field in sub-Saharan Africa (SSA). There remain multiple opportunities for improvement despite ongoing advancements. This report documents the development, and implementation of a pediatric radiation oncology program in Nigeria.</div></div><div><h3>Methods</h3><div>A framework for the development and implementation relevant and feasible in light of local resources was designed. Preparation began in September 2022 and focused on three goals: Patients (improve outcomes and minimize side effects), Professionals (build capacity and multidisciplinary practice), and Protocols (local data and research). Key enabling factors were technology, training, and cohesion. Training, tumor board meetings, and weekly chart rounds, were initiated in collaboration with international experts. Equipment such as pediatric size immobilization devices were procured, and the unit was launched officially in September 2023.</div></div><div><h3>Results</h3><div>The pediatric radiation unit consists of two radiation oncologists, two medical physicists, three radiation therapy technologists, two oncology nurses, and trainees. The facility has three Linear Accelerators enabling the team to deliver conformal radiotherapy (IMRT/VMAT and SBRT). A retrospective review of pediatric cancer treatment at the facility revealed a total of 210 pediatric patients treated between 2020 and 2023 with an average age of 10.9 years. CNS tumors represented 28.1% of cases and 55.7% of patients received radiotherapy (RT). Among those who received RT, 54.7% had treatment breaks, 24.8% abandoned treatment and 75.2% completed their treatment. Recruitment of allied professionals such as physical or rehabilitation therapists specialized in pediatric oncology is a persisting challenge. Future efforts will focus on reducing treatment interruptions and abandonment.</div></div><div><h3>Conclusion</h3><div>Dedicated pediatric radiation oncology programs are an important step to improve pediatric cancer outcomes in SSA. Articulating goals, opportunities, challenges, solutions, and enabling factors as well as investment in capacity building, infrastructure, research, and collaboration are necessary for successful implementation.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Pages e10-e11"},"PeriodicalIF":6.4000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036149","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Pediatric radiation oncology is a rapidly emerging field in sub-Saharan Africa (SSA). There remain multiple opportunities for improvement despite ongoing advancements. This report documents the development, and implementation of a pediatric radiation oncology program in Nigeria.
Methods
A framework for the development and implementation relevant and feasible in light of local resources was designed. Preparation began in September 2022 and focused on three goals: Patients (improve outcomes and minimize side effects), Professionals (build capacity and multidisciplinary practice), and Protocols (local data and research). Key enabling factors were technology, training, and cohesion. Training, tumor board meetings, and weekly chart rounds, were initiated in collaboration with international experts. Equipment such as pediatric size immobilization devices were procured, and the unit was launched officially in September 2023.
Results
The pediatric radiation unit consists of two radiation oncologists, two medical physicists, three radiation therapy technologists, two oncology nurses, and trainees. The facility has three Linear Accelerators enabling the team to deliver conformal radiotherapy (IMRT/VMAT and SBRT). A retrospective review of pediatric cancer treatment at the facility revealed a total of 210 pediatric patients treated between 2020 and 2023 with an average age of 10.9 years. CNS tumors represented 28.1% of cases and 55.7% of patients received radiotherapy (RT). Among those who received RT, 54.7% had treatment breaks, 24.8% abandoned treatment and 75.2% completed their treatment. Recruitment of allied professionals such as physical or rehabilitation therapists specialized in pediatric oncology is a persisting challenge. Future efforts will focus on reducing treatment interruptions and abandonment.
Conclusion
Dedicated pediatric radiation oncology programs are an important step to improve pediatric cancer outcomes in SSA. Articulating goals, opportunities, challenges, solutions, and enabling factors as well as investment in capacity building, infrastructure, research, and collaboration are necessary for successful implementation.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.